AI-focused Drug Portfolio Went DOWN 8% w/e Sept 6th

An Introduction According to research from Grand View Research, the AI-powered drug discovery process is expected to grow by a compound annual growth rate of 30% between now and 2030 and, according to Morgan Stanley, should result in as many as 50 novel therapies being brought to market by then and generate...

Psychedelic Compound Drug Stocks Portfolio DOWN w/e Sept. 6th

An Introduction While the psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come, the stocks of the companies involved are having growing pains. Some Background Shares of clinical-stage companies developing treatments based on psychedelic compound-based...

Funny Munai: With Gustavo Laframboise-Pierre & David Hague

Enlightening and humorous insights into the world's economy by David Hague and  Gustavo Laframboise-Pierre, the Director of Statistical Creation at the European Central Bank. (About David Hauge) Gustavo speaks! Confessions of a Central Banker Today I will be sharing with you, my most recent interview with Gustavo Laframboise-Pierre, the Director of...